US President Donald Trump announced that starting October 1, 2025, a 100% tariff will be imposed on any branded or patented pharmaceutical product unless the company is actively building its pharmaceutical manufacturing plant in the United States. The term "IS BUILDING" will be defined as either "breaking ground" or "under construction." If construction has commenced, these pharmaceutical products will not be subject to the tariff.
This announcement is part of the administration"s ongoing efforts to encourage domestic manufacturing and reduce reliance on foreign pharmaceutical products. The decision has been met with various reactions from industry stakeholders and economic analysts.
For more information on similar situations, see Trump announces 100% tariff on pharmaceuticals not made in America.
Thank you for your attention to this matter.
![[Video] Canada's PM Carney links 15 years of stagnant wages to historical context](/api/image/thumbnails/thumbnail-1758885651356-fi9y6i-thumbnail.jpg)
![[Video] Kamala Harris criticizes president for enriching himself and the wealthy](/api/image/thumbnails/thumbnail-1759021861366-3spitj-thumbnail.jpg)
![[Video] FBI Director Kash Patel: Working with Congress on Epstein materials](/api/image/thumbnails/thumbnail-1759018253847-f6qr6b-thumbnail.jpg)